## Core Concept
The **HHH syndrome**, also known as **Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome**, is a rare urea cycle disorder. This condition arises due to a defect in the transport of ornithine across the mitochondrial membrane. The urea cycle is crucial for the detoxification of ammonia, a byproduct of amino acid catabolism.

## Why the Correct Answer is Right
The HHH syndrome is caused by a defect in the **SLC25A15 gene**, which encodes for the mitochondrial ornithine transporter 1 (ORNT1). This transporter is essential for moving ornithine from the cytosol into the mitochondria, where it participates in the urea cycle. A deficiency in this transporter leads to decreased levels of ornithine within the mitochondria, impairing the urea cycle's function. This results in the accumulation of ammonia, hyperornithinemia, and the production of homocitrulline.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not correspond to the correct genetic defect associated with HHH syndrome.
- **Option B:** This option is incorrect because it is not related to the mitochondrial ornithine transporter.
- **Option C:** Although not explicitly listed, typically, defects in other urea cycle enzymes or transporters lead to different disorders. For instance, defects in carbamyl phosphate synthetase I or ornithine transcarbamylase lead to different urea cycle disorders.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that patients with HHH syndrome present with **hyperammonemia**, which can lead to severe neurological symptoms, including seizures, developmental delay, and episodes of ammonia-induced encephalopathy. Early diagnosis and management, including dietary restrictions and medications to reduce ammonia levels, are critical.

## Correct Answer Line
**Correct Answer: C. SLC25A15**.